Neighborhood Disinvestment and Racial Disparities in Early Hypertension Onset Among Women

• by Elleni M. Hailu, Alexis N. Reeves, Tara McAlexander, Suzanne Judd, Michelle C. Odden

• June 23, 2026

ASE Plenary: Progress, Priorities, and What’s Next

Efforts to align, sustain, and engage drove a year of growth for ASE.

• by Julia Cipriano, MS, CMPP

• June 26, 2026

• 4 min

First MCT8 deficiency therapy approved

Clinical studies showed reductions in circulating thyroid hormone levels and changes in heart rate and systolic blood pressure.

• by Kathryn Wighton

• September 29, 2026

• 3 min

Do Systemic Alpha-2 Agonists Lower Glaucoma Risk?

A large US cohort study found systemic alpha-2 agonist use was associated with a lower hazard of glaucoma-related diagnoses vs. beta-blockers.

• by Andrea Surnit

• July 8, 2026

• 3 min